LISATA THERAPEUTICS, INC. — Director's Dealing 2013

Dec 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2013-12-03

Reporting Person: BERMAN RICHARD J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-12-03	Common stock, par value $0.001 per share	D	1193	$6.29	Disposed	12218	Direct

Footnotes

F1: Shares were returned to NeoStem, Inc. (the "Company") in consideration for an office sublet by Mr. Berman at the Company's corporate headquarters.